5-METHYL-1H-PYRROLO[2,3-C]PYRIDINE-2-CARBOXYLIC ACID, 95.0%, 250mg

7-BROMO-4-CHLORO-8-FLUOROQUINAZOLINE, 95%, 250mg

Octamethyltrisiloxane, >97%, 25g

3-Fluoro-7-methylimidazo[1,2-a]pyridine-2-carboxylic acid, 97%, 100mg

5-Bromo-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine, 95.0%, 25g

2-Amino-4-chloro-6-(trifluoromethyl)pyrimidine, 95.0%, 10g

2,3-Diphenylpropanoic acid, 95.0%, 5g

6-Bromobenzothiophene, 98.0%, 25g

N-([1,1'-Biphenyl]-4-yl)-N-(4'-bromo-[1,1'-biphenyl]-4-yl)-9,9-dimethyl-9H-fluoren-2-amine>98.0%(HPLC)(N)1g

9-Benzyl-3,6-dibromocarbazole>98.0%(GC)(N)1g

(5-Bromo-4-methylpyridin-2-yl)methanol, 95.0%, 250mg

Plan strain-free PLPOLi 10x/0.25 IOS objective for iScope transmitted polarization, no cover glass correction. Working distance 10 mm

[1-(2,4-Dichloro-benzenesulfonyl)-piperidin-4-yl]-methanol, 95.0%, 100mg